Showing 1 - 20 results of 173,572 for search '(( 5 nn decrease ) OR ((( 10 ((_ decrease) OR (a decrease)) ) OR ( 2 mean decrease ))))', query time: 1.25s Refine Results
  1. 1

    Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

    Published 2022
    “…<p>Patients are grouped according to receiving either dipyrone (blue; n = 341) or acetaminophen (red; n = 71) versus patients receiving no antipyretic treatment (n = 315). Graphs display mean differences in temperature decreases between each two comparators (no medication versus dipyrone, no medication versus acetaminophen and dipyrone versus acetaminophen) with their respective 95% confidence intervals. …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc. by Laura L. Stafman (6577184)

    Published 2019
    “…(B) Immunoblotting for the activated form of ERK1/2 –phospho-ERK1/2 (Thr202/Tyr204, Thr185/Tyr187)–and total ERK1/2 revealed a decrease in phospho-ERK1/2 with no accompanying change in total ERK1/2, indicating a decrease in ERK signaling with FTY720 treatment. …”
  12. 12
  13. 13
  14. 14
  15. 15

    Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

    Published 2020
    “…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”
  16. 16
  17. 17

    mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

    Published 2020
    “…<p>(<b>A</b>) Primary cultured podocytes were isolated from <i>Tsc2</i><sup>Δ<i>podocyte</i></sup> and wild-type controls, followed by western blot analyses of TSC2, phospho-4EBP1, LC3B type II, p62, phospho-ULK1, and β-tubulin. …”
  18. 18
  19. 19
  20. 20

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”